competence? this comes on the back of the baby formula shortage but comes in the back of a lot of conflicting advice over vaccines. also some politicalization that was felt in some these vaccine approvals. it is really a bad look for the agency pretty freddy got some people calling for people to be fired or have to step down. this is one of those agencies that we talked about if biden wanted to try to bring some accountability there might be some firings in order. spain thanks to both. we take one more break. we come back hits and misses of the week. it s a storm that crashes, and consumes, replacing thought with worry. but one thing can calm uncertainty. an answer. uncovered through exploration, teamwork, and innovation. an answer that leads to even more answers.
infections, particularly with the emergence of delta. it s not that the vaccines don t work. they work as they re intended to work. which is to prevent severe disease, hospitalization and death. but that should have been a wakeup call that we needed to have a strategy that was broader than vaccines, that there were limitations to what vaccines can and cannot do. and that those limitations are even amly if ied further by the fact that part of the population remains even today some one-third of the united states remains unvaccinated. and so if you want to return to a seblance of normalcy, it s going to require making use of other tools. were you surprised that the administration has been very reticent? they got two vaccine approvals on the mandate. it s almost like everybody whispered this one that did. it should have been a blueprint about how to go about getting more mandates, use what this
12-15-year-olds but the advisory panel, as i understand it how does that work and do you think it is a good decision? no, it is a terrible decision and undermines the trust and the fda. this is the most political and the u.s. history. this is a standard decision. there is a tough call the fda needs to make over authorization. they have done it for most other major aspects of the pandemic for vaccine approvals. for example and the last time they convened, the experts, they voted down boosters for everybody because of concerns about boosting young, healthy people. there are concerns about myocarditis and these are legitimate concerns. one in 1800 young men will develop myocarditis from the second dose of the vaccine. of course, these experts have concern about a third docent population with the risk of dying under age 30 from the primary faxing series is zero. you cannot lower the risk further with a booster.
the resignations coming as the agency nears critical decisions from everything from vaccine approvals to booster shots. why now? we are moments away from the opening bell on wall street. stocks fell on tuesday on what was a quiet day for the markets. they did enjoy solid increases in the month of august. another monthly gain for s&p 500. investors are awaiting the big jobs report on friday which we ll be covering. we ll stay on top of all of it. sales are down from last quarter but we are hoping things will pick up by q3. yeah.uh. doug? sorry about that. umm. what.its.um. you alright? [sigh] [ding] never settle with power e trade. it has powerful, easy-to-use tools
and who may come up to get that, so it may help increase vaccination rates to some extent, but i also think that they are universities and businesses that have been considering putting in vaccine approvals in order to create a safer learning environment, and i think that this announcement from the fda would likely encourage them. sandra: even those who are hesitant to get this until the full fda approval, they might now run out and get it. we will see if it was just an excuse, if they will go out and get it now. but the increased likelihood of mandates here. where does dr. marty makary stand on that? do you support this? we have had them for a long time and health care because we are taking care of individuals who may be vulnerable, and we have had it for the flu shot. i think it makes sense for the covid-19 vaccine as long as we recognize that many health care workers already had it. they have antibodies. when you see a lot of nurses walking off the job, many of